GlassScriptPhysician profile
Smita Lodha
NPI 1356434310
$2,747.26
in general payments reported to CMS, 2019-2025
22 companies · $357 in 2025
The $357 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $210 · 2021: $288 · 2022: $504 · 2023: $190 · 2024: $681 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,228.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $812.04 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $246.09 | 2019-2022 | |
| Boston Scientific Corporation | $217.78 | 2021-2025 | Watchman Flx |
| Abbott Laboratories | $186.70 | 2024-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $151.80 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $138.33 | 2019-2023 | Jardiance, Emgality |
| Dexcom, INC. | $134.77 | 2019-2023 | Dexcom G6 Transmitter |
| Medtronic, INC. | $125.00 | 2022 | |
| Intuity Medical INC | $105.62 | 2022 | |
| Indivior INC. | $73.18 | 2019 | |
| Novartis Pharmaceuticals Corporation | $72.46 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $64.48 | 2019 | |
| Glaxosmithkline, LLC. | $62.68 | 2023 | Arexvy, Shingrix |
| Genentech USA, INC. | $62.57 | 2019-2020 | |
| Amgen INC. | $58.26 | 2024-2025 | Repatha, Otezla, Otezla |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.17 | 2022 | |
| Janssen Pharmaceuticals, INC | $48.31 | 2019 | |
| Amarin Pharma, INC. | $40.45 | 2019 | |
| Radius Health, INC. | $27.49 | 2019-2020 | |
| Exact Sciences Corporation | $24.33 | 2024 | Cologuard Collection Kit |
| Sunovion Pharmaceuticals INC. | $21.79 | 2019 | |
| Kyowa Kirin, INC. | $18.96 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Smita Lodha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.